CODA Biotherapeutics: Funding, Investors & Team (Sep 2026)
CODA Biotherapeutics develops a chemogenetic platform designed to modulate neuronal activity. With chemogenetics, target neuronal populations are modified using gene therapy to express a tunable ligand-gated ion channel. These ligand-gated ion channels are engineered to be highly responsive to a specific proprietary small molecule but are otherwise inactive. The interaction of the small molecule and engineered receptor allows for exquisite, dose-dependent control of the neurons to generate the therapeutic effect.
CODA Biotherapeutics has raised $28.0M across 1 funding round on record, the most recent an undisclosed round of $28.0M announced in Dec 2021.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
CODA Biotherapeutics Company Profile and Key Stats
Latest funding round on record: Dec 2021.
CODA Biotherapeutics Funding Rounds
CODA Biotherapeutics Founders and Leadership Team
Contact details for the CODA Biotherapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →CODA Biotherapeutics Funding Compared to Other Biotechnology Startups
CODA Biotherapeutics' latest round of $28.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like CODA Biotherapeutics in Biotechnology and South San Francisco
Companies Similar to CODA Biotherapeutics
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
CODA Biotherapeutics Funding FAQs
What does CODA Biotherapeutics do?
CODA Biotherapeutics develops a chemogenetic platform designed to modulate neuronal activity. With chemogenetics, target neuronal populations are modified using gene therapy to express a tunable ligand-gated ion channel. These ligand-gated ion channels are engineered to be highly responsive to a specific proprietary small molecule but are otherwise inactive. The interaction of the small molecule and engineered receptor allows for exquisite, dose-dependent control of the neurons to generate the therapeutic effect.
How much funding has CODA Biotherapeutics raised?
CODA Biotherapeutics has raised $28.0M across 1 round on record. The most recent is an undisclosed round of $28.0M announced in Dec 2021.
When did CODA Biotherapeutics last raise funding?
CODA Biotherapeutics' most recent funding round on record is an undisclosed round of $28.0M, announced in Dec 2021.
Who is the CEO of CODA Biotherapeutics?
Kristina Narachi is listed as CEO at CODA Biotherapeutics.
Where is CODA Biotherapeutics headquartered?
CODA Biotherapeutics is based in South San Francisco, California, United States.
How many employees does CODA Biotherapeutics have?
CODA Biotherapeutics is in the 11-50 employee band.
How does CODA Biotherapeutics' funding compare to other Biotechnology startups?
CODA Biotherapeutics' latest round of $28.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's CODA Biotherapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for CODA Biotherapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.